Presentation is loading. Please wait.

Presentation is loading. Please wait.

Contrast-Enhanced Computed Tomography Evaluation of Hepatic Metastases in Breast Cancer Patients Before and After Cytotoxic Chemotherapy or Targeted Therapy 

Published byClemence Day Modified over 5 years ago

Similar presentations

Presentation on theme: "Contrast-Enhanced Computed Tomography Evaluation of Hepatic Metastases in Breast Cancer Patients Before and After Cytotoxic Chemotherapy or Targeted Therapy "— Presentation transcript:

1 Contrast-Enhanced Computed Tomography Evaluation of Hepatic Metastases in Breast Cancer Patients Before and After Cytotoxic Chemotherapy or Targeted Therapy  Hongying He, MD, PhD, Chunyan Cai, PhD, Chusilp Charnsangavej, MD, Richard L. Theriault, MD, Marjorie Green, MD, Mohammad A. Quraishi, PhD, Wei T. Yang, MD  Canadian Association of Radiologists Journal  Volume 66, Issue 4, Pages (November 2015) DOI: /j.carj Copyright © 2015 Canadian Association of Radiologists Terms and Conditions

2 Figure 1 (A) Box plot of sum of lesion size before and after therapy. Change in sum of lesion size is statistically significant in cytotoxic chemotherapy group (P < .0001), but not significant in targeted therapy groups (P = .07; 2-sample t test). (B) Box-plot of mean computed tomography (CT) density before and after therapy. Change in mean CT density is statistically significant in cytotoxic chemotherapy group (P = .05), but not significant in targeted therapy groups (P = .43; 2-sample t test). CX = cytotoxic chemotherapy; TT = targeted therapy. This figure is available in colour online at Canadian Association of Radiologists Journal  , DOI: ( /j.carj ) Copyright © 2015 Canadian Association of Radiologists Terms and Conditions

3 Figure 2 (A) Pretherapy computed tomography (CT) scan in a patient who had received cytotoxic chemotherapy. The metastatic hepatic lesion (indicated by arrow) measures 4.9 cm in size and 86 Hounsfield units (HU) in CT density. (B) Post-therapy CT scan shows the same lesion measuring 2 cm in size and 20 HU in CT density (a 59% decrease in size and 77% decrease in CT density from the pretherapy scan). Canadian Association of Radiologists Journal  , DOI: ( /j.carj ) Copyright © 2015 Canadian Association of Radiologists Terms and Conditions

4 Figure 3 (A) Pretherapy computed tomography (CT) scan in a patient who received targeted therapy. The metastatic hepatic lesion (indicated by arrow) measures 3.5 cm in size and 85 Hounsfield units in CT density. (B) Post-therapy CT scan shows the same lesion measuring 2.4 cm in size and 76 HU in CT density (a 20% decrease in size and 11% decrease in CT density from the pretherapy scan). Canadian Association of Radiologists Journal  , DOI: ( /j.carj ) Copyright © 2015 Canadian Association of Radiologists Terms and Conditions

Download ppt "Contrast-Enhanced Computed Tomography Evaluation of Hepatic Metastases in Breast Cancer Patients Before and After Cytotoxic Chemotherapy or Targeted Therapy "

Similar presentations

Invasive Lobular Cancer of the Breast: A Pictorial Essay of Imaging Findings on Mammography, Sonography, and Magnetic Resonance Imaging  Sarah L. Savaridas,

Invasive Lobular Cancer of the Breast: A Pictorial Essay of Imaging Findings on Mammography, Sonography, and Magnetic Resonance Imaging  Sarah L. Savaridas,
Noriyasu Usami, MD, Shingo Iwano, MD, Kohei Yokoi, MD 

Noriyasu Usami, MD, Shingo Iwano, MD, Kohei Yokoi, MD 
Cumulative Radiation Dose in Patients With Hereditary Hemorrhagic Telangiectasia and Pulmonary Arteriovenous Malformations  Kate Hanneman, MD, Marie E.

Cumulative Radiation Dose in Patients With Hereditary Hemorrhagic Telangiectasia and Pulmonary Arteriovenous Malformations  Kate Hanneman, MD, Marie E.
Assessing the Impact of Incidental Findings in a Lung Cancer Screening Study by Using Low-dose Computed Tomography  Michael J. Kucharczyk, Ravi J. Menezes,

Assessing the Impact of Incidental Findings in a Lung Cancer Screening Study by Using Low-dose Computed Tomography  Michael J. Kucharczyk, Ravi J. Menezes,
Computed Tomography Angiography in Acute Gastrointestinal and Intra-abdominal Bleeding in Children: Preliminary Experience  Dimitri A. Parra, MD, Govind.

Computed Tomography Angiography in Acute Gastrointestinal and Intra-abdominal Bleeding in Children: Preliminary Experience  Dimitri A. Parra, MD, Govind.
Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease  Eisaku.

Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease  Eisaku.
Chia-Lin Hsu, MD, Kuan-Yu Chen, MD, PhD  Journal of Thoracic Oncology 

Chia-Lin Hsu, MD, Kuan-Yu Chen, MD, PhD  Journal of Thoracic Oncology 
Scott J. Adams, MD, Rajan Rakheja, MD, Rhonda Bryce, MD, Paul S

Scott J. Adams, MD, Rajan Rakheja, MD, Rhonda Bryce, MD, Paul S
Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer

Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer
Compression of the Celiac Artery by the Median Arcuate Ligament: Multidetector Computed Tomography Findings and Characteristics  Ozdil Baskan, MD, Emre.

Compression of the Celiac Artery by the Median Arcuate Ligament: Multidetector Computed Tomography Findings and Characteristics  Ozdil Baskan, MD, Emre.
Leptomeningeal and Medullary Response to Second-Line Erlotinib in Lung Adenocarcinoma  Mathilde Wagner, MD, Benjamin Besse, MD, Corinne Balleyguier, MD,

Leptomeningeal and Medullary Response to Second-Line Erlotinib in Lung Adenocarcinoma  Mathilde Wagner, MD, Benjamin Besse, MD, Corinne Balleyguier, MD,
Severe Local Toxicity after Lung Stereotactic Body Radiation Therapy: Lesional Abscess Leading to Bronchocutaneous Fistula Requiring Surgical Marsupialization 

Severe Local Toxicity after Lung Stereotactic Body Radiation Therapy: Lesional Abscess Leading to Bronchocutaneous Fistula Requiring Surgical Marsupialization 
Morphologic Change in Computed Tomography of Aldosterone-Producing Adenoma After Radiofrequency Ablation  Ryan K.L. Lee, FRCR, Shirley Y.W. Liu, FRCS,

Morphologic Change in Computed Tomography of Aldosterone-Producing Adenoma After Radiofrequency Ablation  Ryan K.L. Lee, FRCR, Shirley Y.W. Liu, FRCS,
Multimodality Imaging of Tumour Thrombus

Multimodality Imaging of Tumour Thrombus
Assessing the Impact of Incidental Findings in a Lung Cancer Screening Study by Using Low-dose Computed Tomography  Michael J. Kucharczyk, Ravi J. Menezes,

Assessing the Impact of Incidental Findings in a Lung Cancer Screening Study by Using Low-dose Computed Tomography  Michael J. Kucharczyk, Ravi J. Menezes,
Dose-Length Product to Effective Dose Conversion Factors for Common Computed Tomography Examinations Based on Canadian Clinical Experience  Idris A. Elbakri,

Dose-Length Product to Effective Dose Conversion Factors for Common Computed Tomography Examinations Based on Canadian Clinical Experience  Idris A. Elbakri,
The Burden of False-Positive Results in Analog and Digital Screening Mammography: Experience of the Nova Scotia Breast Screening Program  Jennifer I.

The Burden of False-Positive Results in Analog and Digital Screening Mammography: Experience of the Nova Scotia Breast Screening Program  Jennifer I.
David T. Cooke, MD, Dennis J. Zheng, Karen A. Peterson, NP, Royce F

David T. Cooke, MD, Dennis J. Zheng, Karen A. Peterson, NP, Royce F
Nivolumab Enhances the Inflammation of the Irradiation Field in Advanced Non–Small Cell Lung Cancer  Hiromi Furuta, MD, PhD, Tatsuya Yoshida, MD, PhD,

Nivolumab Enhances the Inflammation of the Irradiation Field in Advanced Non–Small Cell Lung Cancer  Hiromi Furuta, MD, PhD, Tatsuya Yoshida, MD, PhD,
Symptomatic, Obstructive Cardiac Metastasis Can Respond to Chemotherapy  Matthew Cove, MD, Ruth Johnston, MD, Richard Cowan, MD, Philip Haji-Michael, MD 

Symptomatic, Obstructive Cardiac Metastasis Can Respond to Chemotherapy  Matthew Cove, MD, Ruth Johnston, MD, Richard Cowan, MD, Philip Haji-Michael, MD 

Similar presentations

Ads by Google